[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Submit :: Indexing :: Contact Us ::
:: Volume 11, Issue 4 (Winter 2021) ::
JABS 2021, 11(4): 4005-4011 Back to browse issues page
The Role of Probiotics in Parkinson's Disease: A Review Study
Shaden MH. Mubarak 1, Mohammad Ekrahi2, Gaber El-Saber Batiha3 , Mojtaba Memariani4 , Hamed Memariani4 , Abdol Majid Ghasemian5
1- Department of Clinical Laboratory Sciences, Faculty of Pharmacy, University Of Kufa, Iraq , shaden.mh@gmail.com
2- Department of Infectious Diseases, Faculty of Medicine, Fasa University of Medical Sciences, Fasa, Iran
3- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour22511, AlBeheira, Egypt
4- Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5- Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran
Abstract:   (3151 Views)
An upward trend in the incidence of Parkinson’s disease (PD), known as one of the most prominent neurodegenerative maladies, has evoked great concerns among medical community over the past decades. Recently, studies have suggested the initiation of PD in the gastrointestinal tract decades before the advent of manifestations. Accumulating evidence suggests that intracellular deposition of α-synuclein (α-syn) in patients with PD is associated with systemic inflammation leading to the neuroinflammation and neuropsychiatric disorders. The α-syn protein accumulation can be initiated from GI cells and distribute into CNS cells through trans-synaptic cell to cell transmission. Without doubt, gut microbiota affects the enteric nervous system (ENS) known as the “second brain”. Patients with PD have a different balance of bacteria in their intestines, as compared to healthy population. Metabolites from gut microbiota affect the enteric wall such as neurodegeneration. Probiotics have a substantial role in the neutralization or inhibition of reactive oxygen species (ROS) and free radicals and thus improve the PD symptoms. The anti-inflammatory role of probiotics also inhibits the neurodegeneration and PD development. Hence, probiotics contribute to the improvement of PD through several mechanisms which need more in-depth verification.
Keywords: Probiotics, Parkinson's disease, Microbiome, inhibitory mechanisms
Full-Text [PDF 382 kb]   (393 Downloads)    
Type of Study: Review | Subject: Neurology
Received: 2021/02/24 | Accepted: 2021/07/10 | Published: 2022/02/19
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

MH. Mubarak S, Ekrahi M, Batiha G E, Memariani M, Memariani H, Ghasemian A M. The Role of Probiotics in Parkinson's Disease: A Review Study. JABS. 2021; 11 (4) :4005-4011
URL: http://jabs.fums.ac.ir/article-1-2643-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 4 (Winter 2021) Back to browse issues page
Journal of Advanced Biomedical Sciences
Persian site map - English site map - Created in 0.06 seconds with 30 queries by YEKTAWEB 4463